Overview of Dr. Hansen
Dr. Doris Hansen is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from St. George's University School of Medicine and has been in practice 8 years. She is one of 172 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She has more than 30 publications and over 400 citings.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Fax+1 813-449-6713
Education & Training
University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 2018- University of Mississippi Medical CenterResidency, Internal Medicine, 2012 - 2015
St. George's University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2019 - 2026
MS State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant Start of enrollment: 2022 Apr 20
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.Othman Salim Akhtar, Temitope Oloyede, Ruta Brazauskas, Aimaz Afrough, Hamza Hashmi
Blood Advances. 2025-04-08 - Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma.Tobias Tix, Mohammad Alhomoud, Roni Shouval, Gloria Iacoboni, Edward R Scheffer Cliff
Molecular Therapy. 2025-03-31 - Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer
Blood Advances. 2025-03-15
Press Mentions
One CAR T-cell Therapy for Multiple Myeloma Tops Another in Propensity Matched StudyDecember 11th, 2024- Moffitt Study Explores Key Risk Factors to Better Personalize CAR T-cell TherapyDecember 2nd, 2024
- J&J, Legend Solidify Carvykti's Lead in Earlier Multiple Myeloma with Strong Survival ShowingSeptember 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
